期刊文献+

原发性血小板增多症-75例临床分析 被引量:5

Essential Thrombocytemia: Clinical Analysis of 75 Cases
下载PDF
导出
摘要 目的探讨原发性血小板增多症(ET)的临床表现、诊断、治疗及预后。方法对本院1982年5月至2004年4月间诊治的75例ET患者进行回顾性分析。结果男:女=2.6∶1。就诊时中位年龄53岁(17-86岁),有出血者28例(37.3%),有栓塞者21例(28%);因脾大就诊者20例(26.6%);有肝大者13例(13.3%);因其它原因做血常规确诊本病者10例(13.3%);仅有头昏、乏力等非特异性症状者8例(10.6%)。就诊时中位血小板数1 205×109/L (800-2 898×109/L)。骨髓象见巨核细胞明显增生,以产板型与颗粒型为主。45例做骨髓活检,以巨核细胞增生为主,呈异位集簇现象,3例显示网状纤维增生。羟基脲(Hu)治疗有效率(CR+PR)达88%,Hu+干扰素(IFN)治疗有效率达94%。随访18例(1-10年),有5例就诊年龄<40岁者,经Hu治疗半年后不需继续治疗,13例仍在间断治疗中, 病情稳定,2例转为骨髓纤维化,无1例转为AML或MDS者。结论 ET出血与栓塞的发生率相仿。以Hu或Hu+IFN 的治疗可获较好疗效。预后良好。 Objective To investigate the clinical manifestation,diagnosis,treatment and prognosis of essential thrombocytemia( ET). Methods A retorspective analysis was conducted of 75 ET cases treated from May, 1982 to April,2004 in the hospital. Results The median age of the 75 cases (male/female ratio 2. 6: 1 ) on being diagnosed was 53 years (17 -86 years) ,of whom 28 cases (37. 3% ) with hemorrhage,21 cases (28% ) with embolism,20 cases (26. 6% ) seeking medical advice due to splenomegaly ,13 cases (17. 3% ) due to hepatomegaly, and 10 cases ( 13. 3% ) confirmed by routine blood teses due to-other reasons, 8 cases (10. 6% ) exhibiting only such nonspecific symptoms as dizziness or asthenia. The median thrombocyte count when the cases were being diagnosed was 1 205× 109 /L(800 -2 898× 10 /L). Myelogram showed remarkable megakaryocyte proliferation mainly of platelet-forming type and granular type. Bone marrow biopsy was performed in 45 cases showing mainly megakaryocyte proliferation with ectopic aggregation, and 3 cases showing proliferation of reticular fibers. Effective rate( CR + PR) of those treated with hydroxyurea( Hu) was 88% ,and that with Hu + IFN( interferon) was 94% . Of the 18 follow-up cases (1-10 years) ,5 ( less 40 years old when being treated) were free from treatment after halt a year of Hu therapy, 13 were still under discontinuous treatment with stable condition ;2 cases were converted into myelofibrosis but none into AML or MDS. Conclusion The data suggest that the incidence of hemorrhage and that of embolism in ET is similar, and a good therapeutic effect can be achieved with treatment of Hu of Hu + IFN with favorable prognosis.
出处 《血栓与止血学》 2005年第2期70-72,共3页 Chinese Journal of Thrombosis and Hemostasis
关键词 血小板增多症 原发性 羟基脲 干扰素 Trombocytemia Essential Hdroxyurea Interferon
  • 相关文献

参考文献6

二级参考文献8

  • 1Petrideo PE, Beykiech MK, Trapp OM, et al. Anagrelide, a novel platelet lowering option in esscntial thrombocythemia: treatment experimencc in 48 patients in Germany. Eur J Hematol 1998 ;61:71--74.
  • 2Murphy S, Peterson P,Iland H, et al. Experience of the Polycythemia Vera StudyGroup with essential thrombocythemia:a final report on diagnostic criteria,survival,andleukemic transition by treatment .Semin Hematol,1997,34:29~39
  • 3Basses C, Cervantes F, Pereira A, et al. Major vascular complications in essentialthrombocythemia:a study of the predictive factors in a series of 148 patients.Leukemia,1999,13:150~154
  • 4Sterkers Y, Preudhomme C,Lai JL, et al. Acute myeloid leukemia and myelodysplasticsyndromes following essential thrombocythaemia treated with hydroxyura:high proportionof cases with 17p deletion. Blood,1998,91:616~622
  • 5Barbui T, Finazzi G, Dupuy E, et al. Treatment strategies in essentialthrombocythemia:a critical appraisal of various experiences in different centers.Leukemia and Lymphoma,1996,22(Suppl 1):149~160 收稿 1999-03-30 修回 1999-09-10
  • 6杨仁池.原发性血小板增多症研究进展[J].国外医学(输血及血液学分册),1998,21(4):201-203. 被引量:6
  • 7杨仁池,华宝来,钱林生,李大鹏.原发性血小板增多症94例临床分析[J].临床血液学杂志,2000,13(1):8-10. 被引量:29
  • 8吴文,闫骅,赵维莅,徐岚,唐伟,李秀松,沈志祥.羟基脲加干扰素治疗原发性血小板增多症的临床疗效研究[J].临床血液学杂志,2003,16(2):51-54. 被引量:11

共引文献41

同被引文献15

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部